HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: 97/3/852    most recent 00206.2004v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Derave, W. Articles by Hespel, P. Search for Related Content PubMed PubMed Citation Articles by Derave, W. Articles by Hespel, P.

Plasma guanidino compounds are altered by oral creatine supplementation in healthy humans

¹Laboratory of Exercise Physiology and Biomechanics, Faculty of Physical Education and Physiotherapy, Katholieke Universiteite Leuven, B-3001, Leuven; and ²Laboratory of Neurochemistry and Behaviour, Department of Biomedical Sciences, University of Antwerp, B-2020 Antwerp, Belgium

Submitted 1 March 2004 ; accepted in final form 21 April 2004

Although creatine is one of the most widely used nutritional supplements for athletes as well as for patients with neuromuscular disorders, the effects of oral creatine supplementation on endogenous creatine synthesis in humans remains largely unexplored. The aim of the present study was to investigate the metabolic consequences of a frequently used, long-term creatine ingestion protocol on the circulating creatine synthesis precursor molecules, guanidinoacetate and arginine, and their related guanidino compounds. For this purpose, 16 healthy young volunteers were randomly divided to ingest in a double-blind fashion either creatine monohydrate or placebo (maltodextrine) at a dosage of 20 g/day for the first week (loading phase) and 5 g/day for 19 subsequent wk (maintenance phase). Fasting plasma samples were taken at baseline and at 1, 10, and 20 wk of supplementation, and guanidino compounds were determined. Plasma guanidinoacetate levels were reduced by 50% after creatine loading and remained 30% reduced throughout the maintenance phase. Several circulating guanidino compound levels were significantly altered after creatine loading but not during the maintenance phase: homoarginine (+35%), -keto--guanidinovaleric acid (+45%), and argininic acid (+75%) were increased, whereas guanidinosuccinate was reduced (–25%). The decrease in circulating guanidinoacetate levels suggests that exogenous supply of creatine chronically inhibits endogenous synthesis at the transamidinase step in humans, supporting earlier animal studies showing a powerful repressive effect of creatine on L-arginine:glycine amidinotransferase. Furthermore, these data suggest that this leads to enhanced utilization of arginine as a substrate for secondary pathways.

creatine synthesis; urea cycle; ergogenic supplement; neurotoxins

This article has been cited by other articles:

				Y. E. C. Taes, B. Marescau, A. De Vriese, P. P. De Deyn, E. Schepers, R. Vanholder, and J. R. Delanghe Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1330 - 1335. [Abstract] [Full Text] [PDF]

				E. E. Edison, M. E. Brosnan, C. Meyer, and J. T. Brosnan Creatine synthesis: production of guanidinoacetate by the rat and human kidney in vivo Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1799 - F1804. [Abstract] [Full Text] [PDF]

				L. M Stead, J. T Brosnan, M. E Brosnan, D. E Vance, and R. L Jacobs Is it time to reevaluate methyl balance in humans? Am. J. Clinical Nutrition, January 1, 2006; 83(1): 5 - 10. [Abstract] [Full Text] [PDF]